Magnus Andersson - Publications, H-index & Citations

Magnus Andersson

volvo

27H指数

96论文数

2.9K被引数

收录论文 17

发表时间

Cross-Validation Comparison of Digital Twin Approaches Based on Simulated and Measured Road Roughness for Predicting Component Life in Articulated Haulers 基于模拟和实测路面不平度的数字孪生方法交叉验证比较，用于预测铰接式自卸车的部件寿命

ADVANCES IN LEAN MANUFACTURING, VOL 1

IF0

2026-01-01

PREAI

Cramsky, Joel; Kumar, Manoranjan; Rieloff, Ellen; Andersson, Magnus; Danielsson, Per-Olof; Lowe, Welf

Characterization of anisotropic turbulence behavior in pulsatile blood flow (vol 18, pg 9130, 2020)

BIOMECHANICS AND MODELING IN MECHANOBIOLOGY

IF2.7

2021-01-15

OAAI

Andersson, Magnus; Karlsson, Matts

Characterization of anisotropic turbulence behavior in pulsatile blood flow

BIOMECHANICS AND MODELING IN MECHANOBIOLOGY

IF2.7

2020-10-22

OAAI

Andersson, Magnus; Karlsson, Matts

No Significant Relationship Between Ticagrelor and Sleep Apnea in Large, Randomized, Blinded Trials

JACC-CARDIOVASCULAR INTERVENTIONS

IF11.4

2020-04-01

OAAI

Sabatine, Marc S.; Hiatt, William R.; Goto, Shinya; Johnston, S. Claiborne; Bonaca, Marc P.; Steg, P. Gabriel; Bhatt, Deepak L.; Cannon, Christopher P.; Andersson, Magnus; Wallentin, Lars

Grade of leukopenia predicts treatment effect in early breast cancer in patients treated with tailored epirubicin/cyclophosphamide chemotherapy

CANCER RESEARCH

IF16.6

2019-02-15

PREAI

Lindman, H.; Poikonen-Saksela, P.; Ahlgren, J.; Andersson, M.; Bergh, J.; Blomqvist, C.

DBCG 07-READ: A randomized phase III trial comparing six cycles of docetaxel and cyclophosphamide (DC) to three cycles of epirubicin and cyclophosphamide followed by three cycles of docetaxel (EC-D) in patients with early breast cancer

CANCER RESEARCH

IF16.6

2017-02-15

PREAI

Ejlertsen, B.; Tuxen, M. K.; Jakobsen, E. H.; Jensen, M-B; Knoop, A. S.; Hoejris, I.; Ewertz, M.; Balslev, E.; Vestlev, P. M.; Kenholm, J.; Nielsen, D. L.; Bechmann, T.; Andersson, M.; Cold, S.; Nielsen, H. M.; Maae, E.; Arlsen, D. C.; Mouridsen, H. T.

Efficacy and Time-To-Hemostasis of Antegrade Femoral Access Closure Using the ExoSeal Vascular Closure Device: A Retrospective Single-Center Study

EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY

IF6.8

2014-11-01

OAAI

Boschewitz, J. M.; Pieper, C. C.; Andersson, M.; Nadal, J.; Schild, H. H.; Meyer, C.

Safety of pertuzumab plus trastuzumab plus vinorelbine for first-line treatment of patients with HER2-positive locally advanced or metastatic breast cancer

CANCER RESEARCH

IF16.6

2013-12-15

PREAI

Perez, E. A.; Lopez-Vega, J. M.; Del Mastro, L.; Petit, T.; Zamagni, C.; Freudensprung, U.; Bastiere-Truchot, L.; Walker, R.; Andersson, M.

Letter: the impact of smoking on clinical outcomes after endoscopic dilatation in Crohn's disease - authors' reply

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

IF6.7

2013-01-22

OAAI

Gustavsson, A.; Magnuson, A.; Blomberg, B.; Andersson, M.; Halfvarson, J.; Tysk, C.

Long-term effect of tamoxifen use on the risk of contralateral breast cancer

CANCER RESEARCH

IF16.6

2012-12-01

PREAI

Mellemkjaer, L.; Steding-Jessen, M.; Frederiksen, K.; Andersson, M.; Olsen, J. H.

Letter: endoscopic balloon dilatation or strictureplasty for stricturing Crohn's disease? Authors' reply

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

IF6.7

2012-07-16

OAAI

Gustavsson, A.; Blomberg, B.; Andersson, M.; Halfvarson, J.; Tysk, C.

Endoscopic dilation is an efficacious and safe treatment of intestinal strictures in Crohn's disease

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

IF6.7

2012-05-22

103

OAAI

Gustavsson, A.; Magnuson, A.; Blomberg, B.; Andersson, M.; Halfvarson, J.; Tysk, C.

Association studies on 11 published colorectal cancer risk loci

BRITISH JOURNAL OF CANCER

IF6.8

2010-07-20

OAAI

von Holst, S.; Picelli, S.; Edler, D.; Lenander, C.; Dalen, J.; Hjern, F.; Lundqvist, N.; Lindforss, U.; Pahlman, L.; Smedh, K.; Tornqvist, A.; Holm, J.; Janson, M.; Andersson, M.; Ekelund, S.; Olsson, L.; Ghazi, S.; Papadogiannakis, N.; Tenesa, A.; Farrington, S. M.; Campbell, H.; Dunlop, M. G.; Lindblom, A.

Safety assessment of new antithrombotic agents: Lessons from the EXTEND study on ximelagatran

THROMBOSIS RESEARCH

IF3.4

2009-01-01

PREAI

Agnelli, G.; Eriksson, E. L.; Cohen, A. T.; Bergqvist, D.; Dahl, O. E.; Lassen, M. R.; Mouret, P.; Rosencher, N.; Andersson, M.; Bylock, A.; Jensen, E.; Boberg, B.

Is early detection of anastomotic leakage possible by intraperitoneal microdialysis and intraperitoneal cytokines after anterior resection of the rectum for cancer?

DISEASES OF THE COLON & RECTUM

IF3.7

2007-11-01

PREAI

Matthiessen, Peter; Strand, Ida; Jansson, Kjell; Tornquist, Cathrine; Andersson, R. N. Magnus; Rutegard, Jorgen; Norgren, Lars

The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement:: the EXPRESS study

JOURNAL OF THROMBOSIS AND HAEMOSTASIS

IF5

2003-12-01

186

OAAI

Eriksson, BI; Agnelli, G; Cohen, AT; Dahl, OE; Lassen, MR; Mouret, P; Rosencher, N; Kälebo, P; Panfilov, S; Eskilson, C; Andersson, M

Megestrol acetate in advanced, progressive, hormone-insensitive cancer.: Effects on the quality of life:: a placebo-controlled, randomised, multicentre trial

EUROPEAN JOURNAL OF CANCER

IF7.1

1999-04-01

PREAI

Westman, G; Bergman, B; Albertsson, M; Kadar, L; Gustavsson, G; Thaning, L; Andersson, M; Straumits, A; Jeppson, B; Lindén, CJ; Ewers, SB; Andersson, H; Mercke, C; Hafström, L; Birck, O; Orgum, P

研究方向